Next Article in Journal
Effects of Protonation, Hydroxylamination, and Hydrazination of g-C3N4 on the Performance of Matrimid®/g-C3N4 Membranes
Next Article in Special Issue
Plasma and Nanomaterials: Fabrication and Biomedical Applications
Previous Article in Journal
Measurements of Microstructural, Chemical, Optical, and Electrical Properties of Silicon-Oxygen-Nitrogen Films Prepared by Plasma-Enhanced Atomic Layer Deposition
Previous Article in Special Issue
Colloidal Lignin Particles as Adhesives for Soft Materials
Open AccessFeature PaperReview

Antimicrobial Effects of Biogenic Nanoparticles

1
The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
2
Systems and Synthetic Biology Division, Department of Biology and Biological Engineering, Chalmers University of Technology, 41296 Chalmers, Sweden
*
Author to whom correspondence should be addressed.
Nanomaterials 2018, 8(12), 1009; https://doi.org/10.3390/nano8121009
Received: 7 November 2018 / Revised: 3 December 2018 / Accepted: 4 December 2018 / Published: 5 December 2018
(This article belongs to the Special Issue Biomedical Applications of Nanoparticles)
Infectious diseases pose one of the greatest health challenges in the medical world. Though numerous antimicrobial drugs are commercially available, they often lack effectiveness against recently developed multidrug resistant (MDR) microorganisms. This results in high antibiotic dose administration and a need to develop new antibiotics, which in turn requires time, money, and labor investments. Recently, biogenic metallic nanoparticles have proven their effectiveness against MDR microorganisms, individually and in synergy with the current/conventional antibiotics. Importantly, biogenic nanoparticles are easy to produce, facile, biocompatible, and environmentally friendly in nature. In addition, biogenic nanoparticles are surrounded by capping layers, which provide them with biocompatibility and long-term stability. Moreover, these capping layers provide an active surface for interaction with biological components, facilitated by free active surface functional groups. These groups are available for modification, such as conjugation with antimicrobial drugs, genes, and peptides, in order to enhance their efficacy and delivery. This review summarizes the conventional antibiotic treatments and highlights the benefits of using nanoparticles in combating infectious diseases. View Full-Text
Keywords: antibiotics; nanoparticles; biogenic nanoparticles; antimicrobial; antibiotic resistance; multidrug resistant (MDR) microorganisms antibiotics; nanoparticles; biogenic nanoparticles; antimicrobial; antibiotic resistance; multidrug resistant (MDR) microorganisms
Show Figures

Figure 1

MDPI and ACS Style

Singh, P.; Garg, A.; Pandit, S.; Mokkapati, V.R.S.S.; Mijakovic, I. Antimicrobial Effects of Biogenic Nanoparticles. Nanomaterials 2018, 8, 1009.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop